The Role of Thioredoxin in the Aging Process: Involvement of Oxidative Stress

Antioxidants and Redox Signaling

Volumn 5, Issue 5, 2003, Pages 563-570

  Yoshida, Toru ^a   Oka, Shin Ichi ^b   Masutani, Hiroshi ^a,b   Nakamura, Hajime ^a   Yodoi, Junji ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; THIOREDOXIN;

AGING; CELL AGING; CELL PROLIFERATION; ENERGY YIELD; GENE LOCUS; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; LIFESPAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0142182386     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603770310211     Document Type: Short Survey

References (71)

1. Arking R. Biology of Aging, 2nd edit. Sunderland, MA: Sinauer Associates, 1998, pp. 311-364.
2. Bluher M, Kahn BB, and Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299: 572-574, 2003.
3. Brown-Borg HM, Borg KE, Meliska CJ, and Bartke A. Dwarf mice and the ageing process. Nature 384: 33, 1996.
4. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA, and Richon VM. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci U S A 99: 11700-11705, 2002.
5. Chen KS and DeLuca HF. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxy vitamin D-3. Biochim Biophys Acta 1219: 26-32, 1994.
6. Chen Y, Cai J, Murphy TJ, and Jones DP. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem 277: 33242-33248, 2002.
7. Cho CG, Kim HJ, Chung SW, Jung KJ, Shim KH, Yu BP, Yodoi J, and Chung HY. Modulation of glutathione and thioredoxin systems by calorie restriction during the aging process. Exp Gerontol 38: 539-548, 2003.
8. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ, and Partridge L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292: 104-106, 2001.
9. Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, Gustafsson JA, and Spyrou G. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 277: 33249-33257, 2002.
10. De Boer J, Andressoo JO, De Wit J, Huijmans J, Beems RB, van Steeg H, Weeda G, Van Der Horst GT, van Leeuwen W, Themmen AP, Meradji M, and Hoeijmakers JH. Premature aging in mice deficient in DNA repair and transcription. Science 296: 1276-1279, 2002.
11. Dolle ME, Giese H, Hopkins CL, Martus HJ, Hausdorff JM, and Vijg J. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat Genet 17: 431-434, 1997.
12. Feng J, Bussiere F, and Hekimi S. Mitochondrial electron transport is a key determinant of life span in Caenorhabditis elegans. Dev Cell 1: 633-644, 2001.
13. Finch CE. Longevity, Senescence, and the Genome. Chicago, IL: University of Chicago Press, 1990, pp. 497-566.
14. Flurkey K, Papaconstantinou J, Miller RA, and Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A 98: 6736-6741, 2001.
15. Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, and Powis G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res 56: 5765-5770, 1996.
16. Hashimoto S, Matsumoto K, Gon Y, Furuichi S, Maruoka S, Takeshita I, Hirota K, Yodoi J, and Horie T. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 258: 443-447, 1999.
17. Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, and Blasco MA. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18: 2950-2960, 1999.
18. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
19. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, and Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182-187, 2003.
20. Honda Y and Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J 13: 1385-1393, 1999.
21. Honda Y and Honda S. Oxidative stress and life span determination in the nematode Caenorhabditis elegans. Ann N Y Acad Sci 959: 466-474, 2002.
22. Imai S, Armstrong CM, Kaeberlein M, and Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800, 2000.
23. Ishii N, Fujii M, Hartman PS, Tsuda M, Yasuda K, Senoo-Matsuda N, Yanase S, Ayusawa D, and Suzuki K. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 394: 694-697, 1998.
24. Joguchi A, Otsuka I, Minagawa S, Suzuki T, Fujii M, and Ayusawa D. Overexpression of VDUP1 mRNA sensitizes HeLa cells to paraquat. Biochem Biophys Res Commun 293: 293-297, 2002.
25. Johnson TE. Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging. Science 249: 908-912, 1990.
26. Kaeberlein M, McVey M, and Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13: 2570-2580, 1999.
27. Kahlos K, Soini Y, Saily M, Koistinen P, Kakko S, Paakko P, Holmgren A, and Kinnula VL. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma. Int J Cancer 95: 198-204, 2001.
28. Kayser EB, Morgan PG, Hoppel CL, and Sedensky MM. Mitochondrial expression and function of GAS-1 in Caenorhabditis elegans. J Biol Chem 276: 20551-20558, 2001.
29. Kimura KD, Tissenbaum HA, Liu Y, and Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946, 1997.
30. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, and Nabeshima YI. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51, 1997.
31. Kwan KY and Wang JC. Mice lacking DNA topoisomerase IIIbeta develop to maturity but show a reduced mean lifespan. Proc Natl Acad Sci U S A 98: 5717-5721, 2001.
32. Lakowski B and Hekimi S. Determination of life-span in Caenorhabditis elegans by four clock genes. Science 272: 1010-1013, 1996.
33. Larsen PL. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc Natl Acad Sci U S A 90: 8905-8909, 1993.
34. Lin K, Dorman JB, Rodan A, and Kenyon C. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322, 1997.
35. Lin YJ, Seroude L, and Benzer S. Extended life-span and stress resistance in the Drosophila mutant methuselah. Science 282: 943-946, 1998.
36. Liu H, Nishitoh H, Ichijo H, and Kyriakis JM. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 20: 2198-2208, 2000.
37. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, Jaenisch R, and Guarente L. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 20: 3286-3291, 2000.
38. Matsutani Y, Yamauchi A, Takahashi R, Ueno M, Yoshikawa K, Honda K, Nakamura H, Kato H, Kodama H, Inamoto T, Yodoi J, and Yamaoka Y. Inverse correlation of thioredoxin expression with estrogen receptor- and p53-dependent tumor growth in breast cancer tissues. Clin Cancer Res 7: 3430-3436, 2001.
39. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, and Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309-313, 1999.
40. Mitsui A, Hirakawa T, and Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 186: 1220-1226, 1992.
41. Mitsui A, Hamuro J, Nakamura H, Kondo N, Hirabayashi Y, Ishizaki-Koizumi S, Hirakawa T, Inoue T, and Yodoi J. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 4: 693-696, 2002.
42. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, and Stadtman ER. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 98: 12920-12925, 2001.
43. Mounkes LC, Kozlov S, Hernandez L, Sullivan T, and Stewart CL. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 423: 298-301, 2003.
44. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
45. Nakamura H, Bai J, Nishinaka Y, Ueda S, Sasada T, Ohshio G, Imamura M, Takabayashi A, Yamaoka Y, and Yodoi J. Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer. Cancer Detect Prev 24: 53-60, 2000.
46. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, and Pelicci P. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A 100: 2112-2116, 2003.
47. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) upregulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650, 1999.
48. Nonn L, Williams RR, Erickson RP, and Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003.
49. Orr WC and Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263: 1128-1130, 1994.
50. Parkes TL, Elia AJ, Dickinson D, Hilliker AJ, Phillips JP, and Boulianne GL. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat Genet 19: 171-174, 1998.
51. Rogina B, Reenan RA, Nilsen SP, and Helfand SL. Extended life-span conferred by cotransporter gene mutations in Drosophila. Science 290: 2137-2140, 2000.
52. Ruan H, Tang XD, Chen ML, Joiner ML, Sun G, Brot N, Weissbach H, Heinemann SH, Iverson L, Wu CF, Hoshi T, Chen ML, Joiner MA, and Heinemann SH. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci U S A 99: 2748-2753, 2002.
53. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
54. Santa Maria C and Machado A. Effects of development and ageing on pulmonary NADPH-cytochrome c reductase, glutathione peroxidase, glutathione reductase and thioredoxin reductase activities in male and female rats. Mech Ageing Dev 37: 183-195, 1986.
55. Scott BA, Avidan MS, Crowder CM. Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2. Science 296: 2388-2391, 2002.
56. Sun J, Folk D, Bradley TJ, and Tower J. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 161: 661-672, 2002.
57. Suzuki T, Minagawa S, Michishita E, Ogino H, Fujii M, Mitsui Y, and Ayusawa D. Induction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells. Exp Gerontol 36: 465-474, 2001.
58. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, and Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989.
59. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, and Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A 96: 4131-4136, 1999.
60. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S, Nishiyama A, Takeda S, Wada H, Spyrou G, and Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21: 1695-1703, 2002.
61. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, and Garofalo RS. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292: 107-110, 2001.
62. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, and Donehower LA. p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53, 2002.
63. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, and Yodoi J. Redox control of cell death. Antioxid Redox Signal 4: 405-414, 2002.
64. Vogel H, Lim DS, Karsenty G, Finegold M, and Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A 96: 10770-10775, 1999.
65. Wakasugi H, Rimsky L, Mahe Y, Kamel AM, Fradelizi D, Tursz T, and Bertoglio J. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc Natl Acad Sci U S A 84: 804-808, 1987.
66. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, Alt FW, and DePinho RA. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421: 643-648, 2003.
67. Yamanaka H, Maehira F, Oshiro M, Asato T, Yanagawa Y, Takei H, and Nakashima Y. A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochem Biophys Res Commun 271: 796-800, 2000.
68. Yang X, Young LH, and Voigt JM. Expression of a vitamin D-regulated gene (VDUP-1) in untreated- and MNU-treated rat mammary tissue. Breast Cancer Res Treat 48: 33-44, 1998.
69. Yodoi J and Uchiyama T. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today 13: 405-411, 1992.
70. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, and Schellenberg GD. Positional cloning of the Werner's syndrome gene. Science 272: 258-262, 1996.
71. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, and Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A 94: 13215-13220, 1997.